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Abstract
Background: Next generation sequencing enables studying heterogeneous populations of viral infections. When
the sequencing is done at high coverage depth (“deep sequencing”), low frequency variants can be detected. Here
we present QQ-SNV (http://sourceforge.net/projects/qqsnv), a logistic regression classifier model developed for the
Illumina sequencing platforms that uses the quantiles of the quality scores, to distinguish true single nucleotide
variants from sequencing errors based on the estimated SNV probability. To train the model, we created a dataset
of an in silico mixture of five HIV-1 plasmids. Testing of our method in comparison to the existing methods LoFreq,
ShoRAH, and V-Phaser 2 was performed on two HIV and four HCV plasmid mixture datasets and one influenza
H1N1 clinical dataset.
Results: For default application of QQ-SNV, variants were called using a SNV probability cutoff of 0.5 (QQ-SNVD). To
improve the sensitivity we used a SNV probability cutoff of 0.0001 (QQ-SNVHS). To also increase specificity, SNVs
called were overruled when their frequency was below the 80th percentile calculated on the distribution of error
frequencies (QQ-SNVHS-P80).
When comparing QQ-SNV versus the other methods on the plasmid mixture test sets, QQ-SNVD performed similarly
to the existing approaches. QQ-SNVHS was more sensitive on all test sets but with more false positives. QQ-SNVHS-P80
was found to be the most accurate method over all test sets by balancing sensitivity and specificity. When applied to a
paired-end HCV sequencing study, with lowest spiked-in true frequency of 0.5 %, QQ-SNVHS-P80 revealed a sensitivity of
100 % (vs. 40–60 % for the existing methods) and a specificity of 100 % (vs. 98.0–99.7 % for the existing methods). In
addition, QQ-SNV required the least overall computation time to process the test sets.
Finally, when testing on a clinical sample, four putative true variants with frequency below 0.5 % were consistently
detected by QQ-SNVHS-P80 from different generations of Illumina sequencers.
Conclusions: We developed and successfully evaluated a novel method, called QQ-SNV, for highly efficient single
nucleotide variant calling on Illumina deep sequencing virology data.
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Background
Next generation sequencing (NGS) at high coverage depth
(deep sequencing) has proven to be valuable within
clinical virology [1–4]. In order to guide the treatment of
HIV-1 patients, the viral DNA is routinely sequenced to
study the accumulation over time of resistance associated
mutations to antiretroviral drugs. With the advent of NGS
technologies, single nucleotide variants (SNVs) present at
low prevalence (minor variants) can be detected, whereas
with traditional Sanger sequencing, SNVs could be
identified only when present in >20 % of the genomes
in a patient’s sample. However, as NGS technologies
are error-prone, true variants need to be distinguished
from sequencing errors, which is especially challenging for
low frequency variations.
Currently, the Illumina sequencing systems are
dominating the NGS market [5] and novel methodologies
to accurately and efficiently determine genotypic varia-
tions from ultra-deep sequencing (UDS) data for this tech-
nology of sequencers are needed. Moreover, the NGS
system that has in the past most often been used within
virology, i.e. the Roche 454 pyrosequencing [6] system,
will be phased-out by 2016.
Over the last several years multiple groups have devised
algorithms to perform SNV calling on UDS data: ShoRAH
[7], V-Phaser 2 [8], LoFreq [9], deepSNV [10], and RVD
[11, 12]. Whereas the latter two rare variant detection ap-
proaches can robustly detect true variants with a preva-
lence of 0.1 %, the use of these so-called ultrasensitive
methods is limited to experiments where reference control
samples have been included. The former two algorithms
represent 454 legacy methods. Given that for the Illumina
sequencing systems most of the errors observed are mis-
matches, rather than insertion or deletion errors [13]
which are the most prominent errors in pyrosequencing-
based NGS data, these methods may not work optimal for
Illumina NGS data. Lastly, the LoFreq method constitutes
an approach that is developed for variant analysis that cal-
culates p-values assuming a Poisson binomial distribution
as null model for the number of variant bases at a position
in the alignment. In this method, the Illumina sequencer
quality values associated to each base in a column are
taken as input for the null model. While LoFreq is effi-
cient in detecting low frequency SNVs in high-coverage
datasets, efficiency decreases with both the coverage depth
of the dataset and the variant percentage. This means that
LoFreq will need more runtime e.g. to detect a variant at
10 % than at 0.5 % at the same coverage depth.
In this manuscript, we describe Quality Quantile-SNV
(QQ-SNV), a novel logistic regression method for the
highly sensitive and specific detection of true variants
from Illumina UDS data without the need to incorporate
reference control samples in the sequencing experiment.
As opposed to LoFreq we do not model per base the
variant frequency but apply a trained logistic regression
model. Therefore, our novel method does not have the
counterintuitive and undesirable property of being less
efficient in detecting variants at higher frequency. In-
stead of considering all types of variations, such as indels
(as e.g. in [8]), our aim was to develop a novel SNV caller
for detection of true single nucleotide variants only (cf in
[7] and [9]), that is applicable to NGS data of any read
length from different Illumina sequencers. Different from
most of the existing algorithms, QQ-SNV utilizes primarily
the Illumina quality scores associated with individual nu-
cleotides by the sequence basecaller. This approach conse-
quently enables to effectively deal with the alignment of
raw sequence data (“reads”) without any filtering or trim-
ming applied. To improve the classification performance
(“no error” vs. error) of QQ-SNV we first recalibrated the
“raw” quality scores (Additional file 1: Figures S1 and S2)
by means of a companion logistic regression “recalibration”
model. After recalibration [14–16], less discrete (or
more continuous) quality score values are obtained
(Additional file 1: Figures S3 an S4) and the quality score
distribution for the errors is more distinct from the quality
score distributions obtained for the nucleotide reference
or true variants as seen from the density plots and Quality
Quantile plots. This led to the selection of more stable
and information-rich quality score derived model parame-
ters for the QQ-SNV classifier and convergence of the
model fit. Moreover, as the sequencing error frequencies
in forward and reverse reads differ [11, 17–19], the direc-
tionality of the reads is also taken into account within the
regression.
Data and methods
Data
Sequencing
For the HIV and HCV plasmids datasets processed in-
house for training and testing respectively, the Illumina
Genome Analyzer IIx (GAIIx) was used for the paired-
end sequencing. Basecalling was done using Bustard
(CASAVA 1.7.0), the Illumina default basecaller, produ-
cing after de-multiplexing two FASTQ [20] files per
plasmid: FASTQ/1 (reads 1 of paired-end reads) and
FASTQ/2 (reads 2 of paired-end reads, sequenced after
paired-end turn), containing the nucleotide sequences
with a quality score assigned to each nucleotide. Train-
ing of the classifier model was then done on an in silico
plasmid mixture dataset which we created with known
true variant percentages.
Training data
FASTQ/1 Illumina GAIIx retrieved HIV plasmid
sequence data For the training of the classifier model
the HIV PR-RT region (nt 1–1497) was sequenced. Five
HIV-1 plasmids, with different mutational and error
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profile in the HIV protease-reverse transcriptase region
(PR-RT) were processed together in one lane. The length
of the reads was 51 base pairs. As the quality of the
FASTQ/2 reads is typically lower than for the FASTQ/1
reads, for training of the QQ-SNV classifier model and
the companion quality score recalibration model we
used the FASTQ/1 data only. This allowed for better es-
timation of the model parameters with applicability of
the model on paired-end or single-end data. Whereas
the recalibration model was directly trained on the
FASTQ/1 data, to train the classifier model the FASTQ/
1 data was first mixed in silico (see next section).
The mapping of the FASTQ/1 reads was done per
plasmid, where as reference sequence a HXB2 wild type
background was used with the respective plasmid
inserted in the region, at nucleotide position 2253–3749,
where the true sequence was known. Within this
1497 bp region, 12 SNV positions contained a true vari-
ant (Additional file 2: Table S1), hence all differences to
the HXB2 reference seen at other positions are true er-
rors. Note that for this read mapping, we opted to not
make a choice between the different read mapping tools
[21]. Instead, regular expressions (perl) were used to
search for the best possible ungapped alignment for the
reads in forward or reverse direction. In total 1,183,162
reads covering the region 2253-3749 and having < 20 %
mismatch nucleotide errors (including mismatch errors
caused by not considering insertions or deletions) were
retained for training of the quality score recalibration
model. In this training data an equal percentage of
reads in forward and reverse direction was observed
(Additional file 2: Table S2). Coverage of the reads
was comparable for all plasmids, with a similar average
coverage range: 8388–9871 reads with exception of plas-
mid 2 where the average coverage was found to be lower
(N = 3788 reads) (Additional file 1: Figure S5).
In Additional file 2: Table S3, for each of the five plas-
mids, the total number of errors observed in the region
2253–3749 is given as well as the per plasmid PHRED
quality scores calculated from the plasmid error prob-
abilities, where a high quality score indicates a smaller
probability of error.
In silico HIV plasmid mixtures data set for training
the QQ-SNV classifier To train a model with high sen-
sitivity and specificity to detect true variants present at
low frequency, a dataset (hereafter called the ground set)
was generated of 960 HIV plasmid mixture re-samplings
of the FASTQ/1 reads from five plasmids (described in
the previous section), as mapped in the region 2253–3749
(Additional file 1: Figure S5, Additional file 2: Table S2).
For each re-sampling, reads were mixed in silico from
a multinomial distribution in the plasmid mixture
proportion 63, 30, 5, 1.5, and 0.5 %, and having a coverage
depth of N = 5000. In total, the number of true variants in
the ground set was 11,520 (=960 × 12), with true
variant percentages populated in the range [0.22–100 %]
(Additional file 1: Figure S6). In order to obtain a larger
coverage depth for training of the QQ-SNV model ten re-
samplings in the ground set were repeated for the same
plasmid mixture proportion and their read mappings were
combined. This resulted in a training dataset consisting of
96 read sets (training samples) with a coverage depth of
50,000 reads at each nucleotide position.
Test data
HIV plasmid mixture dataset 1 The HIV PR-RT region
(nt 1–3332) was sequenced using the Illumina GAIIx se-
quencer with a single-end library layout mixing 6 plas-
mids at the ratio of 88.889, 10, 1, 0.1, 0.01, and 0.001 %
[10]. The FASTQ file was obtained from the European
Nucleotide Archive (ERX097243), and the length of the
reads was 31 base pairs. Mapping to the HXB2 reference
sequence (nt 2044–3615) was done using CLC Genomics
Workbench (CLC bio, Aarhus, Denmark) using
the default alignment settings. The average coverage
depth of the plasmid mixture in the PR-RT region
considered for the analysis (nucleotide position 2253–3584)
was 103,142 reads.
HIV plasmid mixture dataset 2 The HIV IN region
(nt 145–545) was sequenced using the Illumina HiSeq
2000 sequencer with a single-end library layout mixing 6
plasmids at the ratio of 60, 33.4, 5, 1, 0.5, and 0.1 % [22].
The FASTQ file was obtained from the European Nucleo-
tide Archive (PRJEB5053), and the length of the reads was
50 base pairs. Mapping to the HXB2 reference sequence (nt
4349–4799) was done using CLC Genomics Workbench
(CLC bio, Aarhus, Denmark) using the default alignment
settings. The average coverage depth of the plasmid mix-
ture in the IN region considered for the analysis (nucleotide
position 4374–4774) was 3,857,069 reads.
HCV plasmid mixture datasets The HCV NS3 region
(nt 1–543) was sequenced using the Illumina GAIIx
sequencer with a paired-end library layout. In the lab
experiment, a HCV reference plasmid was mixed four
times with a non-reference plasmid containing five true
variants in the NS3 region (nucleotide position 3420–
3962) considered for the analysis: 3525G >A, 3527C >G,
3882C >A, 3883G > A, and 3884G >A, where the spike-in
percentage of the non-reference plasmid (and thus all five
true variants) was 0.5, 1, 2, and 10 %, respectively. The
four resulting HCV “spiked-in” plasmids were sequenced
in different lanes, and the length of the reads was 70
base pairs. Mapping to the HCV subtype b reference se-
quence (nt 3420–3962, Genbank accession number
AJ238799) was done using CLC Genomics Workbench
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(CLC bio, Aarhus, Denmark) using single-end alignment
with the default settings, and the average coverage depth
(reads 1 and 2) for the plasmids was 93,130 reads. Illumina
sequencing data has been deposited in the European
Nucleotide Archive under study accession number
PRJEB5028. To test our method in comparison to the
existing methods at different sequencing depths we
generated lower coverage data by randomly downsampling
the sequence alignment files (SAM files) of the four HCV
“spiked-in” plasmid mixtures containing all paired-end
reads using Picard command line tools v1.86 Downsample-
Sam. Reads were retained with a probability of 40, 10, 2.5
and 0.625 % resulting in average coverage depths of 37,270,
9291, 2295, and 561 reads, respectively.
H1N1 clinical dataset The H1N1 neuraminidase (NA)
reference and single-end alignments of the paired-end
reads of the H1N1 BN3 clinical data sample, sequenced
with both Illumina GAIIx (on one lane) and Illumina
MiSeq, were obtained from [12]. The length of the reads
was 37 base pairs. To test the performance in variant de-
tection of QQ-SNV, the region at position 405–425 was
considered, containing four SNVs called in [12], at the
positions 410, 413, 415, and 421. After merging the
alignments of the paired-end reads 1 and 2 using sam-
tools v0.1.18 [23], the average coverage depth in this re-
gion was 360,359 reads and 36,812 reads for GAIIx and
MiSeq, respectively.
No ethics approval was required for the use of the
NGS data of the clinical isolate in this study. The BN3
clinical sample is one of the H1N1 infected patient sam-
ples of which the Illumina GAIIx and MiSeq sequencing
data was made publicly available by Stanford University
as publication material with the RVD method [12] on
their server at URL: http://hamachi.stanford.edu/publi-
cation-material/rvd/clinical/.
Methods
The goal of this paper is to build a logistic regression
model to classify a nucleotide variant as SNV (true
variant) or as error by exploiting the information that is
in the distribution of the quality scores in the reads cover-
ing the variant location. Therefore in this section we first
introduce the Illumina quality scores of which we assume
that the empirical estimate of the distribution differs for
true variants or nucleotide reference compared to an error
at each location (Additional file 1: Figures S1 and S2).
Second, we put forward our companion logistic re-
gression “recalibration” model to recalibrate these
quality scores with as purpose to further increase the
“distance” between the quality score distribution of
“no error” vs. error (Additional file 1: Figures S3 and S4).
Third, we define the “distance metrics” which are derived
from the per nucleotide recalibrated quality score
distributions and are considered to be selected as
predictors for the QQ-SNV classifier to model the
probability of “no error” vs. error for each nucleotide
at each position (Additional file 1: Figures S7-S9).
Then, we describe how the in silico plasmid mixture
QQ-SNV training data was generated by utilizing a
resampling scheme and present the QQ-SNV model
and how we selected and estimated the QQ-SNV
model parameters by applying stepwise regression
and weighted logistic regression, respectively. The
latter approach corrects for imbalances in the train-
ing data (less SNVs than errors) and allows to use a
probability threshold of 0.5 for default application of
QQ-SNV. Next, we give the complete workflow for
running the QQ-SNV classifier on new data, includ-
ing the implementation of a high sensitivity threshold
of 0.0001 and frequency-based variant filtering to in-
crease sensitivity and reduce the number of false
positives, respectively. Lastly, we give the parameter
settings used for the competing SNV calling methods
on the test datasets.
Quality scores and derived predictors
Quality scores Illumina quality scores QUAL are
retrieved from a FASTQ file and indicate the base call
accuracy as assigned to the nucleotides by the basecaller
software of the Illumina sequencer. Quality scores Q are
so-called PHRED scores when they have the property of
being logarithmically related to the base calling error
probability P: Q = − 10 log10P. While on the FASTQ/1
training data the llumina quality scores QUAL are in
the Q-range 2–40, quality score recalibration (described
in the next section) gave quality scores in the Q-range
1.62–27.6 – thus estimating the error probability P to
be higher.
Recalibrated quality scores While correct interpretation
of the quality scores may not seem to be required when
mainly used for constructing predictors in the QQ-SNV
model, we found that quality score recalibration improved
the QQ-SNV classification performance (Additional file 2:
Table S4 and Additional file 1: Figure S10). When evaluat-
ing the QQ-SNV model generation procedure, a major
observation was that more continuous quality score values
led to the selection of more stable and information-rich
quality score derived model parameters as well as con-
vergence of the model fit and an increased “distance”
between the quality score distribution of “no error” vs.
error. Hence, we have integrated quality score recali-
bration in the QQ-SNV workflow by means of logistic
regression, as previously employed in [14, 16]. Here, to
calculate the recalibrated quality scores for deriving the
predictors of the QQ-SNV model, we trained the
following companion binary logistic regression model
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on the FASTQ/1 HIV plasmid sequence data (1,183,162
reads from five HIV plasmids, see section Training data)
with as outcome YFASTQ/1 = 0 (no error) or 1 (error):
log it Probability of YFASTQ=1 ¼ 1
  ¼ α0 þ α1  QUALþ α2  RELPOS;
where YFASTQ/1 i,j,k,r =I{nucleotide k at position j in read r
of sample i is a sequencing error} and the probability
that YFASTQ/1 i,j,k,r is a sequencing error is calculated from
the covariates QUALi,j,k,r and RELPOSi,j,k,r. QUAL is the
original nucleotide Illumina PHRED quality score to be
recalibrated. RELPOS is the distance of the nucleotide
position in the read from the 3’ end, normalized by the
read length. The recalibrated PHRED quality score is
then calculated as: Q. RECALi,j,k,r = − 10 log10(Prob-
ability YFASTQ/1 i,j,k,r is a sequencing error).
The coefficients of the QQ-SNV recalibration model are
given in Table 1 (confidence intervals in Additional file 3),
and were fitted using a mixed effects model, using a ran-
dom effect for factor PLASMID to take the difference in
plasmid error probability into account (Additional file 2:
Table S3) [24]. The random effect variance was 0.199.
Quality score derived predictors Whereas the quality
score recalibration model is a logistic regression model
that predicts the probability of sequencing error at the
nucleotide level for each individual read r, the QQ-SNV
model calculates the probability of “no sequencing error”
of a nucleotide k for all reads of a sample i mapped at a
position j, using the recalibrated quality 100-quantiles
(percentiles) p – calculated from multiple reads with the
same direction d (forward/reverse) and containing the
same nucleotide k (A/C/G/T) at an aligned position j –
as summarized quality scores. The following “distance
metrics” were derived per read direction from the per
nucleotide recalibrated quality score distributions:
QQnorm. dir calculates the recalibrated quality quantile
percentages after normalization to the “per position j”
recalibrated quality quantile (calculated irrespective of
nucleotide) in the range [0,1] (Additional file 1: Figure
S11), thus independent of the Illumina recalibrated Q-
range (Additional file 1: Figure S4). QQ. dir then calculates
per percentile p the nucleotide distance in the range [0,1]
as the difference of the normalized nucleotide k recali-
brated quality quantile from the reference value of 100 %,
relative to the distance calculated for the nucleotide with
the worst quality (Additional file 1: Figure S12). After that
D. dir is calculated as the total distance summed over all
nineteen percentiles p considered (Additional file 1: Figure
S13). In the formula given below QQnorm. dirp,i,j,k,d, QQ.
dirp,i,j,k,d, and D. diri,j,k,d are calculated for nucleotide k in
the aligned reads for sample i at position j in a sequenced
region of interest and per read direction d.
QQnorm:dirp;i;j;k;d ¼ percentilepðQ:RECALi;j;k read:direction ¼ dj Þ
percentilep

Q:RECALi;jj read:direction ¼ d;nt∈ A;C;G;T ;Nf g
 ;
withp∈ 5th; 10th; …; 95th
 
;
d∈ forward; reversef g
QQ:dirp;i;j;k;d ¼
max 0; 1−QQnorm:dirp;i;j;k;d
  
1−minnt¼k QQnorm:dirp;i;j;k;d
   ;
withk∈ A;C;G;Tf g
D:diri;j;k;d ¼
X
p∈P
QQ:dirp;i;j;k;d; with P ¼ 5th; 10th; …; 95th
 
;
d∈ forward; reversef g
Next, the “distance metrics” selectable for the QQ-
SNV model: QQnorm (Additional file 1: Figure S7), QQ
(Additional file 1: Figure S8), and D (Additional file 1:
Figure S9) are calculated as follows:
QQnormp;i;j;k ¼ minðQQnorm:dirp;i;j;k;forward;
QQnorm:dirp;i;j;k;reverseÞ
QQp;i;j;k ¼ max QQ:dirp;i;j;k;forward;QQ:dirp;i;j;k;reverse
 
Di;j;k ¼ max D:diri;j;k;forward;D:diri;j;k;reverse
 
Thus, they retain the distance terms corresponding to
the read direction d (forward/reverse) having the largest
difference between the nucleotide k and the “per position
j” recalibrated PHRED quality quantile scores. Hence, as
read directionality is taken into account, SNV calling using
the QQ-SNV model can be performed for all variants
present at least once in both forward and reverse direction.
Training dataset for classifier model selection and
parameter estimation
Resampling scheme for the generation of the training
data To generate the training dataset of 96 in silico
HIV plasmid mixtures, 96 (=5! – 4!) plasmid mixture
re-samplings were generated ten times for each of the
permutations of plasmid percentages at the ratio of
63, 30, 5, 1.5, and 0.5 %. Note that for plasmid 2 the
highest percentage (63 %) could not be assigned be-
cause of the lower number of available reads. The ten
repeats per permutation were then combined to have
a larger coverage depth for training the QQ-SNV
Table 1 Quality score recalibration model trained on FASTQ/1
GAIIx data
Parameter Coefficient Significance (P-value)
Intercept 0.84 (α0) 2.27e-5
QUAL −0.16 (α1) <2e-16
RELPOS −0.89 (α2) <2e-16
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model. Moreover, to also have a balanced training
dataset in terms of coverage, the coverage depth at
each nucleotide position in the mapping region 2253-
3749 of the 96 plasmid mixture training samples was
chosen to be N = 50,000 reads. Thereto, the re-
samplings in the ground set of 960 (96 × 10) plasmid
mixtures were guided by filling up each row in the
read mapping with reads from the same plasmid,
starting at a nucleotide position with the same sam-
pled offset position (0–50). Consequently N = 5000
reads were multinomially distributed over the five
plasmids with probabilities cf a given permutation,
covering the whole region 2253–3749. Next, to allow
for additional errors the bases were recalled and the
alignment steps were performed separately for the
960 read sets, each containing a selection of ~150,000
reads (12.7 %) from the original FASTQ/1 dataset.
This implies that for each of the read sets first the
Illumina Cluster Intensity Files (CIFs) were recreated,
retaining the intensities of the subset of reads from
the respective re-sampling. Second the basecalling
was executed with the Bustard Off-Line Basecaller.
Third, the read set was mapped to the HXB2 refer-
ence sequence (nt 2203-3799) using CLC Genomics
Workbench (CLC bio, Aarhus, Denmark) using the
default alignment settings.
QQ-SNV classifier model selection and parameter esti-
mation Training of the QQ-SNV classifier model was
performed on 96 in silico HIV plasmid mixture data
samples (see section Training data), resulting in the fol-
lowing binary logistic regression model with as outcome
Yin silico = 0 (no error) or 1 (error):
logit Probability of Yin silico ¼ 0ð Þ ¼ β0 þ β1  QQnorm5th þ
β2  QQnorm25th þ β3  QQnorm95th þ
β4  QQ80th þ β5  D
where Yin silico i,j,k = I{nucleotide k at position j of sample
i is a sequencing error}.
In a stepwise regression procedure, using a signifi-
cance level (p-value threshold) of 5E-4 for entering or
removing of covariates, the following five quality score
derived predictors were selected for the QQ-SNV model:
QQnorm5th , QQnorm25th , QQnorm95th , QQ80th , and D. To
increase the sensitivity of the QQ-SNV model when
classifying variants, having a predicted SNV probability
above 0.5, as being true, the QQ-SNV model coefficients
(Table 2) were fitted using weighted binary logistic re-
gression to correct for the imbalances in the training
data (less SNVs than errors), with weighting factors of
25 and 1 in case of “no sequencing error” and sequen-
cing error, respectively. These weighting factors for re-
scaling of the probabilities for a SNV probability
threshold of 0.5 were chosen to match the false positive :
false negative ratio of the unweighted trained model as
used to select the quality score derived predictors using
as cutoff 0.008 (=12/1497 = the percentage of SNV posi-
tions in training region) (Additional file 1: Figure S14).
Running QQ-SNV
We have developed a workflow to perform QQ-SNV
classification on a new dataset (Fig. 1a). First, an
alignment containing the reference mapped FASTQ/1
and/or FASTQ/2 reads needs to be exported as a
SAM file [23]. In case the alignment has been saved
as a BAM file (binary format) instead, a conversion
to the SAM format can be made using samtools [23].
Second, the quality scores of the nucleotides in the reads
are to be recalibrated using the quality score recalibration
model, and the nucleotide recalibrated quality percentiles
and distance metrics, needed in the QQ-SNV model, are
to be calculated per aligned nucleotide position and direc-
tion of the reads (forward/reverse). Finally, the QQ-SNV
classifier model is used for the SNV calling, classifying a
variant as SNV (true variant) – if the QQ-SNV model pre-
dicted SNV probability is above a threshold value of 0.5
(QQ-SNVD (default)) – or as a sequencing error (Fig. 1b).
While in the training of the QQ-SNV model we rescaled
the SNV probabilities for a probability cutoff of 0.5 (see
previous section), when applying logistic regression on
multiple different datasets the optimal classification
threshold on these datasets is rarely exactly 0.5 [25].
Therefore, to increase the sensitivity of the QQ-SNV clas-
sifier in detecting low frequency variants, for QQ-SNVHS
(high sensitivity) the model coefficients as shown in Table 2
were still used, but now using a SNV probability threshold
of 0.0001 (Fig. 1c). Thus, in order to obtain high sensitivity
on new data this high sensitivity threshold is taken 15
times lower than the lowest SNV probability obtained for
a true variant in the ground set of 960 samples, which was
0.00153. However, to avoid the occurrence of many false
positives by taking a much lower SNV probability
threshold than default, we calculated in addition the
50th/75th/80th/85th/90th/95th percentile of the QQ-
SNVHS distribution (frequency cutoff c) of “error”
(variants with P(SNV) ≤ 0.0001) frequencies. To reduce
Table 2 QQ-SNV model trained on 96 in silico HIV plasmid
mixture data samples
Parameter Coefficient Significance (P-value)
Intercept −117.66 (β0) <2e-16
QQnorm5th 4.38 (β1) <2e-16
QQnorm25th 7.37 (β2) <2e-16
QQnorm95th 116.78 (β3) <2e-16
QQ80th −3.06 (β4) <2e-16
D −0.70 (β5) <2e-16
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false positives, “SNVs” (variants with P(SNV) > 0.0001) are
overruled when their frequency is lower than c (Fig. 1d).
The specificity of QQ-SNVHS will increase when choosing
a higher percentile to calculate the frequency threshold.
When evaluating QQ-SNVHS using the above different
percentiles on the test sets (see section Test data), using
the 80th percentile (P80) as frequency cutoff was overall
most accurate (see section Results). Therefore, we suggest
to use QQ-SNVHS-P80 on new datasets.
To run QQ-SNV on the different datasets as analyzed in
this paper, we wrote a perl script QQ-SNV_workflow.pl
(Additional file 4). Within the QQ-SNV workflow, SAS
9.2 was used for the SNV calling. The SAS default per-
centile definition was used for calculation of the quality
quantiles and frequency thresholds.
Parameter settings of competing methods
ShoRAH ShoRAH v0.8 was run. The largest window
size was used that worked with the software, corre-
sponding to the sequencing read length. For the other
parameters, the default settings were used.
V-Phaser 2 V-Phaser 2 v2.0 was run using the default set-
tings, applying strand bias test and correction for multiple
testing.
LoFreq LoFreq v0.5.0 was run using the default settings.
Results
Training performance and method validation of QQ-SNV
Training of QQ-SNVD on the in silico HIV plasmid mix-
ture data with coverage N = 50,000 reads (96 samples
with different plasmid mixture proportion), sequenced
on the Illumina GAIIx platform (51 bp reads), resulted
in 99.2 % sensitivity, 99.9 % specificity, and Positive Pre-
dictive Value (PPV) of 75 % (Additional file 2: Table S4).
The 9 true variants not detected were present at the
lowest frequency of 0.5 %. In addition, we analyzed the
performance of QQ-SNV on the ground set in silico
HIV plasmid mixture data with coverage N = 5000 reads
(960 samples with ten repeats re-sampled for the 96
plasmid mixture proportions as used in the training
data) (Additional file 2: Table S5). Here, besides QQ-
BAM SAM
QQ-SNV
error SNV
A Illumina NGS
FASTQ/1
FASTQ/2
alignment
get recalibrated quality percentiles
classification
QQ-SNVD
error SNV
variantsB
P(SNV)  0.5 P(SNV) > 0.5
QQ-SNVHS
error SNV
C variants
P(SNV)  0.0001 P(SNV) > 0.0001
QQ-SNVHS-P80
VNSrorre
error
variantsD
P(SNV)  0.0001 P(SNV) > 0.0001 and freq > c
P80 frequency cutoff c
P(SNV) > 0.0001 
and freq c
Fig. 1 QQ-SNV variant calling. Schematic view of QQ-SNV variant calling methodology starting from Illumina NGS data. a QQ-SNV workflow
b QQ-SNVDc QQ-SNVHSd QQ-SNVHS-P80, 80
th percentile (P80) of the QQ-SNVHS distribution of “error” frequencies was used as frequency cutoff to
decrease the number of false positives obtained with QQ-SNVHS
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SNVD we evaluated QQ-SNVHS and QQ-SNVHS-P50/75/90
using as frequency threshold the 50th/75th/90th percent-
ile (P50, P75 and P90) of the frequency distribution of
variants called as error by QQ-SNVHS. The sensitivity of
the methods in detecting the true variants was calculated
for different intervals on the true variant frequencies.
For QQ-SNVD both sensitivity and specificity are above
95 %, but the PPV of 19.6 % is low. The latter is due to
the in silico resampling at a relatively low coverage depth
of 5000 reads and the presence of variants at true percent-
ages below 0.5 % (Additional file 1: Figure S6). QQ-
SNVHS achieves 100 % sensitivity, but the number of false
positives is much higher. When applying QQ-SNVHS-P90
the number of false positives is clearly reduced in com-
parison to QQ-SNVHS and the sensitivity in detecting
variants with prevalence < 0.5 % is high (99.7 %) (Add-
itional file 2: Table S5), thus validating the extended ver-
sion of the QQ-SNVHS approach (Fig. 1d). On the test
data in the next sections, then in addition the 80th, 85th
and 95th percentile (P80, P85 and P95) were calculated of
the QQ-SNVHS distribution of “error” frequencies. QQ-
SNVHS-P80 resulted in the best overall performance.
Performance evaluation of QQ-SNV on HIV plasmid
mixture datasets
The results of the performance comparison of the differ-
ent methods on the HIV plasmid mixture dataset 1 se-
quenced on the Illumina GAIIx platform (31 bp reads)
are given in Table 3, Additional file 1: Figure S15A and
Additional file 2: Table S6. The sensitivity in detecting
variants ≥ 1 % is similar for the different methods, except
for V-Phaser 2. However, the latter method was equally
sensitive as QQ-SNVHS-P80 in detecting SNVs at 0.1 %.
Note that QQ-SNVHS-P80 was also more robust than
QQ-SNVD in detecting variants at percentages ≥ 10 %.
By overruling 92 % of the QQ-SNVHS false positives, the
specificity of QQ-SNVHS-P80 is similar as for the existing
methods. The computationally most efficient method
was QQ-SNV (14 m), followed by V-Phaser 2 (33 m),
LoFreq (53 m), and ShoRAH (6h25m).
The results of the performance comparison of the differ-
ent methods on the HIV plasmid mixture dataset 2 se-
quenced on the Illumina HiSeq 2000 platform (50 bp
reads) are given in Table 4, Additional file 1: Figure S15B
and Additional file 2: Table S7. V-Phaser 2 failed on this
Table 3 Performance on HIV plasmid mixture dataset 1
QQ-SNVD QQ-SNVHS-P80
a LoFreq ShoRAH V-Phaser 2
Variant % sens.b sens.b sens.b sens.b sens.b
88.889 % 57/61 60/61 59/61 56/61 20/61
10 % 44/50 49/50 47/50 45/50 13/50
1 % 28/34 30/34 23/34 26/34 10/34
0.1 % 2/42 20/42 0/42 7/42 22/42
0.01 % 0/40 1/40 0/40 3/40 8/40
0.001 % 0/30 0/30 0/30 0/30 0/30
FPc FPc FPc FPc FPc
2 4 0 6 2
timede timede timedf timedg timedg
14m11s 14m11s 53m24s 6h25m 33m5s
a80th percentile of the QQ-SNVHS distribution of “error” frequencies was used
as frequency cutoff to decrease the number of false positives obtained
with QQ-SNVHS
bsens. is the percentage of true variants that were correctly called as SNV
cFP is the number of variants incorrectly called as SNV
dcomputation time in hours (h), minutes (m) and seconds (s)
eWindows 7 64 bit, 8GB RAM, 3.2GHz
fLinux Ubuntu 12.04.4, 57.6 GB RAM, one core (2.3GHz) used
gLinux Ubuntu 12.04.4, 57.6 GB RAM, 8 cores (2.3GHz) used in parallel
Table 4 Performance on HIV plasmid mixture dataset 2
QQ-SNVD QQ-SNVHS-P80
a LoFreq ShoRAH V-Phaser 2
Variant % sens.b sens.b sens.b sens.b sens.b
40.0 % 2/2 2/2 2/2 1/2 nah
39.9 % 1/1 1/1 1/1 1/1 nah
39.5 % 1/1 1/1 1/1 0/1 nah
38.9 % 1/1 1/1 1/1 0/1 nah
38.4 % 2/2 2/2 2/2 2/2 nah
34.4 % 2/2 2/2 2/2 1/2 nah
34.0 % 1/1 1/1 1/1 1/1 nah
33.5 % 1/1 1/1 1/1 1/1 nah
33.4 % 8/8 8/8 8/8 7/8 nah
6.6 % 1/1 1/1 1/1 1/1 nah
6.1 % 1/1 1/1 1/1 0/1 nah
5.1 % 1/1 1/1 1/1 1/1 nah
5.0 % 8/8 8/8 8/8 8/8 nah
1.0 % 10/10 10/10 9/10 7/10 nah
0.6 % 0/1 1/1 1/1 0/1 nah
0.5 % 5/8 8/8 8/8 2/8 nah
0.1 % 1/10 6/10 2/10 2/10 nah
FPc FPc FPc FPc FPc
0 1 0 3 nah
timede timede timedf timedg timedg
2h29m 2h29m 2d4h11m 57m45s nah
a80th percentile of the QQ-SNVHS distribution of “error” frequencies was used
as frequency cutoff to decrease the number of false positives obtained
with QQ-SNVHS
bsens. is the percentage of true variants that were correctly called as SNV
cFP is the number of variants incorrectly called as SNV
dcomputation time in days (d), hours (h), minutes (m) and seconds (s)
eWindows 7 64 bit, 8GB RAM, 3.2GHz
fLinux Ubuntu 12.04.4, 57.6 GB RAM, one core (2.3GHz) used
gLinux Ubuntu 12.04.4, 57.6 GB RAM, 8 cores (2.3GHz) used in parallel
hNo results could be obtained for the V-Phaser 2 algorithm due to failure of
the V-Phaser 2 software tool on our server
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dataset. Although ShoRAH was the fastest method in pro-
ducing results, too many variants at high and low frequen-
cies were not detected. Thus QQ-SNV and LoFreq remain
for the comparison. QQ-SNVHS-P80 was more sensitive
than LoFreq at 1.0 % (100 vs. 90 %) and at 0.1 % (60 vs.
20 %). For QQ-SNVHS-P80 one false positive was returned
which was not eliminated when applying a P95 frequency
threshold (Additional file 2: Table S7), while for LoFreq
there were no false positives. On this dataset QQ-SNV
was twenty times faster than LoFreq (2h29m vs.
2d4h11m). This confirms that LoFreq is slow in detecting
variants at high frequency, whereas for QQ-SNV the
runtime is entirely due to the high coverage depth (>1 mil-
lion reads).
Performance evaluation on HCV plasmid mixture datasets
The results of the performance comparison of the differ-
ent methods on the HCV plasmid mixture datasets se-
quenced on the Illumina GAIIx platform (70 bp reads)
are given in Table 5, Additional file 1: Figures S15C-D
and Additional file 2: Table S8. Similarly as on HIV plas-
mid mixture dataset 1, for V-Phaser 2 the sensitivity in
detecting variants at higher percentages is low. Both
QQ-SNVHS and LoFreq were the only methods with
Table 5 Performance on HCV plasmid mixture datasets
QQ-SNVD QQ-SNVHS-P80
a LoFreq ShoRAH V-Phaser 2
Variant % Pair sens.b FPc sens.b FPc sens.b FPc sens.b FPc sens.b FPc
0.50 % 1d 5/5 10 5/5 38 5/5 36 5/5 2 5/5 11
0.50 % 2e 0/5 0 0/5 0 0/5 0 0/5 0 3/5 15
0.50 % 1 + 2f 1/5 0 5/5 0 2/5 5 2/5 7 3/5 32
1 % 1d 5/5 11 5/5 53 5/5 62 5/5 2 5/5 13
1 % 2e 1/5 0 5/5 0 5/5 1 2/5 1 2/5 28
1 % 1 + 2f 3/5 1 5/5 0 5/5 7 4/5 1 3/5 45
2 % 1d 5/5 13 5/5 64 5/5 72 5/5 4 2/5 20
2 % 2e 3/5 0 5/5 0 5/5 1 3/5 0 3/5 14
2 % 1 + 2f 5/5 0 5/5 0 5/5 7 5/5 2 3/5 28
10 % 1d 5/5 6 5/5 42 5/5 75 5/5 0 3/5 10
10 % 2e 5/5 0 5/5 0 5/5 0 5/5 0 2/5 28
10 % 1 + 2f 5/5 0 5/5 0 5/5 8 5/5 1 2/5 56
timegh timegh timegi timegj timegj
0.50 % 1d 2m27s 2m27s 1m30s 1h45m 8m7s
0.50 % 2e 2m18s 2m18s 1m33s 9h29m 22m3s
0.50 % 1 + 2f 4m42s 4m42s 3m36s 15h4m 2h31m
1 % 1d 2m56s 2m56s 2m27s 1h38m 10m51s
1 % 2e 3m1s 3m1s 2m6s 8h46m 46m44s
1 % 1 + 2f 5m48s 5m48s 5m56s 13h13m 3h46m
2 % 1d 2m35s 2m35s 2m6s 1h34m 10m25s
2 % 2e 2m32s 2m32s 1m53s 8h50m 41m1s
2 % 1 + 2f 4m59s 4m59s 4m34s 14h56m 1h47m
10 % 1d 3m5s 3m5s 4m26s 1h46m 13m45s
10 % 2e 2m30s 2m30s 2m35s 14h13m 33m24s
10 % 1 + 2f 5m29s 5m29s 9m53s 7h57m 1h47m
a80th percentile of the QQ-SNVHS distribution of “error” frequencies was used as frequency cutoff to decrease the number of false positives obtained
with QQ-SNVHS
bsens. is the percentage of true variants that were correctly called as SNV
cFP is the number of variants incorrectly called as SNV
dReads 1 of paired-end reads
eReads 2 of paired-end reads (sequenced after paired-end turn)
fAll paired-end reads
gcomputation time in hours (h), minutes (m) and seconds (s)
hWindows 7 64 bit, 8GB RAM, 3.2GHz
iLinux Ubuntu 12.04.4, 57.6 GB RAM, one core (2.3GHz) used
jLinux Ubuntu 12.04.4, 57.6 GB RAM, 8 cores (2.3GHz) used in parallel
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100 % sensitivity for the reads 1, reads 2, and combined
reads 1 and reads 2 data for true variant frequencies ≥
1 %. While QQ-SNVHS detects all variants but one
(reads 2 at 0.5 %), the number of false positives on reads 1
data is higher than for the other methods. On the reads 1
data, best performance was seen for ShoRAH. When ap-
plying a P80 frequency threshold on the QQ-SNVHS
SNVs, similar specificity as LoFreq was obtained on the
reads 1 data. On the combined reads 1 and reads 2 data
only QQ-SNVHS-P75 and QQ-SNVHS-P80 achieved an ac-
curacy of 100 % (Additional file 2: Table S8) at all true
variant frequencies. As seen from the Receiver Operating
Characteristic (ROC) curves at different coverage depth
(Additional file 1: Figures S16-S19), the performance of
QQ-SNV is best at the highest sequencing depth and be-
comes worse for non-UDS datasets (Additional file 2:
Table S9). The same is observed for the other methods,
although for ShoRAH we note better performance at 10 %
downsampling than at 40 % downsampling or for the full
HCV plasmid mixture datasets (all paired-end reads)
(Additional file 2: Table S9 and Table 5).
Paired-end vs. single-end data
Although, on these HCV data sets QQ-SNVHS-P80 ob-
tained perfect performance on the combined reads 1
and reads 2 data, on the reads 1 data QQ-SNVD is more
accurate than QQ-SNVHS-P80.
Computational efficiency
For QQ-SNV the runtime needed increased linearly with
coverage and was independent of variant frequency
(Fig. 2 and Table 5), whereas for LoFreq computational effi-
ciency decreased for detection of variants at 10 %. At a
coverage depth of 98,800 reads for the combined reads 1
and reads 2 data QQ-SNV was 1.8 times faster than LoFreq
(5m29s vs. 9m53s). V-Phaser 2 and ShoRAH needed con-
siderably more time: 1h47m and 7h57m, respectively. For
detection of variants ≤ 2 % computational efficiency of QQ-
SNV was similar as for LoFreq (Fig. 2 and Table 5).
Performance evaluation on H1N1 clinical dataset
The results of the performance comparison of the differ-
ent methods on a H1N1 clinical sample, sequenced on
Illumina GAIIx and MiSeq platforms (37 bp reads) are
given in Table 6 and Additional file 2: Table S10. Here,
variants in the region 405–425 of the neuraminidase
gene were all present at a very low frequency below
0.5 %. In [12], four SNVs were called at the positions
410, 413, 415, and 421, and the other seventeen posi-
tions were considered “non-variant”.
Paired-end vs. single-end data
From the GAIIx data, QQ-SNVD did not detect any of these
four SNVs (Table 6). From the MiSeq reads 1 or reads 2
data, 2/4 of these SNVs could be detected by QQ-SNVD.
Only for the MiSeq combined reads 1 and reads 2 data QQ-
SNVD had 100 % sensitivity in detecting these four SNVs, at
a specificity of 82.4 % (percentage of “non-variants” in [12],
also classified as “non-variant” by QQ-SNV) (Table 6). In
contrast, QQ-SNVHS and QQ-SNVHS-P50/P75/P80/P85/P90/
P95 was 100 % sensitive when presented with either
GAIIx/MiSeq reads 1 data, reads 2 data, or the combined
reads 1 and reads 2 data (Table 6 and Additional file 2:
Table S10). Due to failure, paired-end results could
not be obtained for V-Phaser 2 on both the GAIIx
and MiSeq data and for ShoRAH on the MiSeq data.
Effect on different Illumina sequencer types
Whereas, the four SNVs were consistently detected from
both GAIIx and MiSeq data using QQ-SNVHS or QQ-
Fig. 2 QQ-SNV vs. other methods: computational efficiency on HCV plasmid mixture datasets. On the x-axis is the coverage, which is the average
number of reads per position. On the y-axis is the computation time in minutes. A reference line is shown at 5 and 60 min. The size of the data
points (reads 1, reads 2 and reads 1 + 2) shown for the different HCV datasets corresponds to the variant percentage (0.5 %, 1 %, 2 % and 10 %)
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SNVHS applying a SNV frequency threshold (Table 6
and Additional file 2: Table S10), none of the SNVs were
detected from the other methods on the MiSeq data
(Table 6). However, V-Phaser 2 and LoFreq were able to
detect one and three SNVs from the GAIIx data, re-
spectively. ShoRAH did also not detect any of the SNVs
from the GAIIx data (Table 6).
When comparing the specificity of QQ-SNVHS-P80 for
the two platforms, a higher specificity was obtained from
GAIIx versus MiSeq data: 76.5–94.1 % vs. 64.7–88.2 %.
Table 7 lists the different positions where a nucleotide
variant was classified as SNV by QQ-SNVHS-P80 from the
combined reads 1 and reads 2 data for GAIIx and MiSeq.
For the GAIIx data, the four SNVs considered to be true
were detected in the frequency range [0.25–0.35 %],
whereas the variants called as SNV by QQ-SNVHS-P80 only
were in the frequency range [0.13–0.18 %]. For the MiSeq
data, the four SNVs were detected in the frequency
range [0.14–0.28 %], and the variants called as SNV by
QQ-SNVHS-P80 only were in the frequency range [0.07–
0.10 %]. For the MiSeq data, two variants with fre-
quency < 0.1 % had high predicted SNV probabilities
0.882 and 0.999 (Table 7), although they were not called
as SNV on the GAIIx. While a reason could be that a
higher coverage was used on the GAIIx compared to
MiSeq, it might indicate that the lower limit of reliable
detection was exceeded.
The Quality Quantile plot for the nucleotides at NA
position 410 for the combined reads 1 and reads 2 data,
and for both GAIIx and MiSeq is shown in Fig. 3. The
Table 6 Performance on H1N1 clinical sample
QQ-SNVD QQ-SNVHS-P80
a LoFreq ShoRAH V-Phaser 2
Illumina sequencer Pair sens.b FPc sens.b FPc sens.b FPc sens.b FPc sens.b FPc
GAIIx 1d 0/4 0 4/4 2 2/4 0 0/4 0 1/4 0
GAIIx 2e 0/4 0 4/4 1 3/4 0 0/4 0 0/4 0
GAIIx 1 + 2f 0/4 0 4/4 4 3/4 0 0/4 0 nak nak
MiSeq 1d 2/4 1 4/4 5 0/4 0 0/4 0 0/4 0
MiSeq 2e 2/4 0 4/4 2 0/4 0 nak nak 0/4 0
MiSeq 1 + 2f 4/4 3 4/4 6 0/4 0 nak nak nak nak
timegh timegh timegi timegj timegj
GAIIx 1d 12m51s 12m51s 7m46s 6h1m 43m15s
GAIIx 2e 13m5s 13m5s 7m55s 6h41m 43m6s
GAIIx 1 + 2f 21m56s 21m56s 19m1s 2h18m nak
MiSeq 1d 1m11s 1m11s 26 s 5h46m 3m40s
MiSeq 2e 1m23s 1m23s 24 s nak 3m55s
MiSeq 1 + 2f 2m45s 2m45s 1 m nak nak
a80th percentile of the QQ-SNVHS distribution of “error” frequencies was used as frequency cutoff to decrease the number of false positives obtained
with QQ-SNVHS
bsens. is the percentage of SNVs as identified in [12] that were called as SNV by QQ-SNV in region 405–425 of NA gene in H1N1 BN3 sample
cFP is the number of “non-variants” in [12] that were called as SNV by QQ-SNV
dReads 1 of paired-end reads
eReads 2 of paired-end reads (sequenced after paired-end turn)
fAll paired-end reads
gcomputation time in hours (h), minutes (m) and seconds (s)
hWindows 7 64 bit, 8GB RAM, 3.2GHz
iLinux Ubuntu 12.04.4, 57.6 GB RAM, one core (2.3GHz) used
jLinux Ubuntu 12.04.4, 57.6 GB RAM, 8 cores (2.3GHz) used in parallel
kNo result could be obtained for the ShoRAH/V-Phaser 2 algorithm due to failure of the ShoRAH/V-Phaser 2 software tool on our server
Table 7 SNVs called by QQ-SNVHS-P80 on H1N1 clinical sample
(all paired-end reads)
GAIIx MiSeq SNV identified
in [12]Positiona Percentageb P(SNV)c Percentageb P(SNV)c
406 nad nad 0.09 % 0.99923 No
409 0.13 % 0.00110 0.10 % 0.00517 No
410 0.35 % 0.05514 0.28 % 0.60047 Yes
411 0.13 % 0.00016 0.09 % 0.00318 No
413 0.26 % 0.00482 0.14 % 0.98815 Yes
415 0.25 % 0.00207 0.16 % 0.98665 Yes
418 0.18 % 0.00011 0.09 % 0.00769 No
421 0.26 % 0.04058 0.16 % 0.94675 Yes
423 0.15 % 0.00012 0.08 % 0.02083 No
425 nad nad 0.07 % 0.88219 No
aNucleotide position in neuraminidase (NA) gene
bObserved frequency of single nucleotide variant called by QQ-SNV
cProbability that variant is a SNV, as predicted by QQ-SNV
dNot classified as SNV by QQ-SNVHS-P80, P(SNV) ≤ 0.0001
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distance between the recalibrated quality quantile curves
of the nucleotide C and the reference nucleotide T is small
enough for QQ-SNVHS-P80 to detect the SNV 410 T > C.
This distance is smaller for the MiSeq data compared to
the GAIIx data, which is reflected in a higher QQ-SNV
predicted SNV probability for MiSeq (0.60 vs. 0.055). For
sequencing errors the curve in forward direction can look
very different from the curve reflecting the reverse direc-
tion (e.g. 410 T >G for MiSeq).
Discussion
We described our novel method for SNV calling on
NGS data of viral populations, called QQ-SNV, and
compared its performance to the existing methods
LoFreq, V-Phaser 2 and ShoRAH. Our methodology dif-
fers from these other methods in using a logistic regres-
sion model. Therefore, QQ-SNV is more related to the
regression classifier methods in [16, 18] that were devel-
oped for SNV detection in a genome wide and low
coverage situation, whereas the goal of our method is to
detect true variants at low frequency on ultra-deep se-
quencing datasets. Furthermore, we aimed for a method
that can be applied on different Illumina datasets with-
out retraining of the model. Thereto, the QQ-SNV
model was trained on a multi-sample dataset of in silico
plasmid mixtures, without using any sequence context
specific covariates for the model. Instead, we introduced
“distance metrics” as covariates to compare the nucleo-
tide quality quantiles to the “per position” reference
quality. For future research, incremental further im-
provement of the QQ-SNV model might be possible, e.g.
by exploration of other distance metrics in a simulation
study or by implementing an extension of our method
to enable to call variants at the codon level [26, 27] in
addition to SNVs.
In comparison with many of the existing methods, the
QQ-SNV method is a computational lightweight variant
detection method that limits pre- and post-processing of
the data. This results from taking as input the “raw” read
mapping data, no filtering or trimming is required.
Error-recalibration is incorporated, but QQ-SNV does
not perform error-correction (unlike e.g. ShoRAH). Al-
though QQ-SNV returns the “observed” frequency per-
centages of the true variants (thus, biased by the errors),
the nucleotide counts are not used inside the method.
For QQ-SNV a strand bias test filter is not needed as
read directionality is already used in the regression,
whereas for e.g. V-Phaser 2 applying a strand bias test
led to not detecting SNVs at the higher percentages.
Moreover, whereas in a strand bias test one assesses dif-
ferences in frequency, the novelty of the QQ-SNV
method is in evaluating differences in quality instead.
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Fig. 3 Quality Quantile plot. SNV 410 T > C is called by QQ-SNVHS-P80 both on GAIIx and MiSeq for H1N1 clinical sample BN3 [12] at position 410
of the neuraminidase (NA) gene
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For default application of QQ-SNV, using a SNV prob-
ability cutoff of 0.5 (QQ-SNVD), no filtering needs to be
applied after classification. Whereas QQ-SNVD has simi-
lar performance as the existing methods, to increase sen-
sitivity a QQ-SNV probability cutoff of 0.0001 was used
(QQ-SNVHS). Here, to avoid many false positives one
frequency based variant filtering step was implemented
to overrule SNVs called by QQ-SNVHS when the ob-
served frequency is below the 80th percentile calculated
on the QQ-SNVHS distribution of “error” frequencies
(QQ-SNVHS-P80). On the test sets the results obtained
with QQ-SNVHS-P80 were consistent for the different
Illumina platforms: GAIIx, MiSeq and HiSeq 2000. Al-
though the training of our model has been performed
on a fixed read length of 51 bp, QQ-SNV is developed
for any read length. Therefore, for verification we per-
formed the QQ-SNV workflow (Fig. 1) on 250 bp se-
quencing reads of an influenza A plasmid mixture
dataset [28]. This confirmed applicability of QQ-SNV for
read lengths enabled by the current Illumina sequencers
(Additional file 5). Based on the presented results we
suggest, regardless of quality of the data obtained or the
Illumina platform used for the sequencing, to use QQ-
SNVHS-P80 to detect true variants at low frequency as
well as at higher frequencies on the combined reads 1
and reads 2 data (in case of paired-end data), or on reads
1 data (in case no paired end data is available). However,
in case specificity is considered more important than
sensitivity QQ-SNVD can be applied instead. In case sin-
gle end data is processed separately and paired end data
is also available, our recommendation to use QQ-SNVD
vs. QQ-SNVHS-P80 on the single end data is cf given
below. QQ-SNV does not need reference control sam-
ples. Yet in case these are available, running QQ-SNV
on the controls might give indication on how to more
optimally choose the SNV probability cutoff and/or the
variant frequency threshold to be used for the clinical
samples in the experiment.
Although on the newest Illumina machines quality deg-
radation should no longer be a major issue for reads 2
data of paired-end reads [13], for both the HIV and HCV
plasmids data, a lower quality was observed for the reads
2 compared to the reads 1 data. Therefore, it could be
valuable in case paired-end sequencing data was obtained
not to perform the variant detection on the combined
reads 1 and reads 2 data only, but as a quality check also
for the reads 1 and/or reads 2 data, separately. When sep-
arately processing the reads 1 and/or reads 2 data, paired
end information could then also be used in deciding
whether to apply QQ-SNVD or QQ-SNVHS-P80 for the
“final” single-end variant calling, by using the following
two rules: I) If the number of variants identified using
QQ-SNVHS-P80 on the reads 1 and reads 2 data combined
is lower than the number of variants identified using QQ-
SNVHS-P80 on the reads 1 data, then use QQ-SNVD for
the final variant calling on the reads 1 data, else use QQ-
SNVHS-P80. II) If by the above rule QQ-SNVD is used for
the final variant calling on the reads 1 data and if the
number of variants identified using QQ-SNVD on the
reads 2 data is larger than the number of variants identi-
fied using QQ-SNVD on the reads 1 data then use QQ-
SNVD for the final variant calling on the reads 2 data, else
use QQ-SNVHS-P80. While we did not notice quality deg-
radation of the reads 2 data for the H1N1 clinical sample,
the predicted SNV probabilities were higher for MiSeq
than for GAIIx. However, we note that on the MiSeq the
experiment was performed with a 10-fold lower coverage
depth than on the GAIIx.
Conclusions
We have developed QQ-SNV for single nucleotide vari-
ant detection from NGS deep sequencing data. Different
from the existing methods ShoRAH and V-Phaser 2,
QQ-SNV is tailor-made for the Illumina NGS systems, a
platform expected to be increasingly used for clinical
diagnostic purposes. Our focus on the error profile of a
single NGS technology, combined with the fact that we
trained a regression model on a multi-sample dataset
designed to contain true variants with percentages
populated in the range [0.5-100 %], contributed to the
improved performance of QQ-SNV in detecting vari-
ants in comparison to the ShoRAH, and V-Phaser 2
algorithms, and in detecting low frequency variants in
comparison to LoFreq.
Importantly, instead of modeling nucleotide counts or
using any particular sequence specific knowledge, we
use the recalibrated quality quantiles, which were calcu-
lated per read direction, as the only main parameters in
the QQ-SNV model to predict SNV probabilities from
the observed quality distributions of the nucleotides
present at a particular position in the read mapping.
Therefore, in addition to the analysis of viral population
data, as exemplified in this manuscript, QQ-SNV could
potentially also be applied to any other type of heteroge-
neous population data.
Finally, QQ-SNV has the advantage of being extremely
computationally efficient in handling “ultradeep” read
sets, since SNV calling is reduced to a classification
method based on logistic regression.
Availability and requirements
Project name: QQ-SNV
Project home page: http://sourceforge.net/projects/qqsnv/
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Any restrictions to use by non-academics: none
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